Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of April 19, 2020.
Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of April 19, 2020.
FDA Approves Sanofi's Quadrivalent Meningococcal Vaccine
The US Food and Drug Administration has approved a biologic license application for MenQuadfi meningococcal (Groups A, C, Y, W) conjugate vaccine. The approval was granted to Sanofi for the prevention of invasive meningococcal disease in persons 2 years and older.
MenQuadfi is the only FDA approved quadrivalent meningococcal vaccine that is indicated for individuals 2 through 56 years of age and older.
Read the full article.
FDA Grants EUA to LabCorp's At-Home COVID-19 Test Kit
The US Food and Drug Administration (FDA) has issued an emergency use authorization to LabCorp for at-home coronavirus disease 2019 (COVID-19) tests kits.
Under this authorization, nasal swab specimens can be collected at home using the Pixel by LabCorp COVID-19 collection kit. A health care provider must recommend the test and patients must complete a COVID-19 questionnaire prior to testing.
Read the full article.
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.